Updates

MPAC

April 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

MPAC’s shares have made further headway since my last update, with the company introducing its new “Going for Growth” five-year roadmap, aiming to broadly double revenue and improve margins (adj. EBIT margin approximately 10%) in five years. This follows strong FY23 results, which also reported a stuffed closing order book of £72m. Having stalled in the early part of the year, revenues improved as the year progressed, going from +4% in H1 to +30% in H2, resulting in a full-year outturn of +17% to £114.2m (a major milestone, exceeding £100m), while pretax profit increased by 103% to £7.1m, with eps up 94% to 25.9p. The Food & Beverage sector accounted for 40% of revenue, with Healthcare at 36% and clean energy contrib ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Nexteq

Revolution Beauty

MPAC - Two large acquisitions will ensure forecast beat (November 2024)

MPAC - Enhances its US footprint with acquisition (October 2024)

Mpac (June 2024)

MPAC - Plans to double sales within five years (May 2024)

Mpac (February 2024)

MPAC (August 2023)

Mpac (April 2023)

Mpac Group - Clean energy opportunity (February 2023)

Mpac (August 2022)

Mpac - Order intake in year >£100m (April 2022)

Mpac Group - Resilient performance for FY21 (February 2022)

MPAC - Lollies driving sales of packaging equipment in US (October 2021)

Mpac (August 2021)

Mpac (May 2021)

Mpac - Trading ahead of forecast (February 2021)

Mpac Group - Enters fast growing craft beer packaging market (October 2020)

Mpac - Noticeable resilience in healthcare sector (August 2020)

Mpac (April 2020)

Mpac - Meeting notes (March 2020)

Mpac - Five profit upgrades in FY19 (February 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X